Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study

Background: Graves' disease is one of the most common autoimmune conditions, but treatment remains imperfect. This study explores the first-in-human use of antigen-specific immunotherapy with a combination of two thyrotropin receptor (TSHR) peptides (termed ATX-GD-59) in Graves' hyperthyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Simon H.S., Dayan, Colin, Wraith, David C., Barrell, Kevin, Olive, Natalie, Jansson, Lotta, Walker-Smith, Terrie, Carnegie, Christina, Martin, Keith F., Boelaert, Kristien, Gilbert, Jackie, Higham, Claire E., Muller, Ilaria, Murray, Robert D., Perros, Petros, Razvi, Salman, Vaidya, Bijay, Wernig, Florian, Kahaly, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Immunology, Autoimmunity, and Graves’ Ophthalmopathy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648194/
https://www.ncbi.nlm.nih.gov/pubmed/31194638
http://dx.doi.org/10.1089/thy.2019.0036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648194/
https://www.ncbi.nlm.nih.gov/pubmed/31194638
http://dx.doi.org/10.1089/thy.2019.0036

Ejemplares similares